Takeda Announces Continuation of the Long-Term Incentive Plan for Members of the Board of Directors in Fiscal 2018
Takeda Pharmaceutical Company Limited announced that the meeting of the Board of Directors resolved to continue the long-term incentive plan (“LTI”) for members of...
AstraZeneca is advancing clinical practice in respiratory medicine with new data at the American Thoracic Society 2018 International Congress
AstraZeneca and MedImmune, its global biologics research and development arm, will present updates from its respiratory medicines and pipeline at the American Thoracic Society...
Alnylam Appoints Colleen Reitan to the Board of Directors
Alnylam Pharmaceuticals, Inc , the leading RNAi therapeutics company, announced the appointment of a veteran healthcare leader, Colleen Reitan, to Alnylam’s Board of Directors,...
Lupin’s Nagpur facility US FDA inspection concluded with no observations
Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility. The inspection concluded without...
Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the ASCO and the Congress of the European Hematology Association (EHA) Annual Meetings
Takeda Pharmaceutical Company Limited announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming medical meetings: the 54th...
Celgene to Present New Clinical Data in Blood Cancer and Solid Tumor Therapies at Upcoming American Society of Clinical Oncology Scientific Sessions
Celgene Corporation announced that data from more than 60 company-sponsored, cooperative group and investigator-initiated clinical studies evaluating Celgene agents will be presented at the...
AbbVie to Show Progress and Growth in Oncology Research at the American Society of Clinical Oncology 2018 Annual Meeting
AbbVie , a research-based global biopharmaceutical company, announced it will present data about the company's portfolio of investigational oncology medicines during the American Society...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...